JD vs REPL
JD.com Inc Adr (JD) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
REPL does not have a complete income-statement cache yet.
JD currently screens at market cap $45.56B and trailing P/E 7.6. REPL currently screens at market cap $825.7M.
Not investment advice. Open the JD and REPL stock pages for the full models.
Not investment advice.